NWK Group’s Halozyme HALO Stock Holding History

NWK Group’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-950	Closed	-$40K	–	121
2021 Q1	$40K	Buy	+950	New	+$43.4K	0.02%	115

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NWK Group's HALO Position: Q2 2021 in Review

NWK Group sold out of Halozyme (HALO) in Q2 2021, closing a stake of 950 shares — an estimated $40K sold.

NWK Group first reported a position in HALO in Q1 2021 and held it in 1 quarter. The position peaked at $40K in Q1 2021. 313 funds tracked by Wall St. Rank hold HALO as of Q2 2021.

NWK Group reported no remaining Halozyme position as of Q2 2021 after selling out during the quarter.
NWK Group sold 950 Halozyme shares in Q2 2021, an estimated $40K.
NWK Group first reported a position in Halozyme in Q1 2021 and held it in 1 quarter.
NWK Group's Halozyme position peaked at $40K in Q1 2021.
313 funds tracked by Wall St. Rank held Halozyme as of Q2 2021.

Based on NWK Group's 13F filing for Q2 2021, filed 16 Aug 2021.